HELLO BIO
LIVE

Serial Number

79372993

Owner

Hello Bio Limited

Attorney

Mark Lerner, Esq.

Filing Date

Mar 29, 2022

Add to watchlist:

No watchlists yet
View on USPTO

HELLO BIO Trademark

Serial Number: 79372993 • Registration: 7682957

HELLO BIO is a trademark filed by Hello Bio Limited on March 29, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Hello Bio Limited

Unit 3,

Entity Type: 99

Trademark Details

Filing Date

March 29, 2022

Registration Date

February 11, 2025

Published for Opposition

December 24, 2024

Goods & Services

Education and training services, namely, conducting programs in the field of science, chemistry, biology, biochemistry or life science and the distribution of course materials, namely, scientific, chemical, biological, biochemical or life science papers and publications, guides, and calculators for scientific education and training in connection therewith; non-downloadable electronic publications, namely books, magazines, brochures about life sciences for use by medical professionals in the field of science and medicine; online non-downloadable publications, namely scientific, chemical, biological biochemical or life science papers and publications; arranging and conducting of conferences, seminars and exhibitions in the field of biochemistry, clinical chemistry and microbiology and the distribution of course materials, namely, scientific, chemical, biological, biochemical or life science papers and publications, guides, and calculators for scientific education and training in connection therewith; advisory and consultancy services in connection with all of the aforesaid services

Chemical and bio-chemical products, preparations and substances for life science research and for use in biochemistry, clinical chemistry and microbiology; chemical reagents other than for medical or veterinary purposes; chemical reagents for laboratory use, other than for medical or veterinary purposes; chemical test reagents, other than for medical or veterinary purposes; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents and buffers for scientific use; reagent kits comprising generic DNA circle, DNA primers polymerase and buffers for use in biotechnology fields; chemical preparations and substances for use in scientific analysis and research; chemical preparations and substances for biological and genetic research; biochemical products used in science and in laboratory analysis, namely, receptors, nuclear receptors; receptor agonists and receptor anti-agonists; chemogenetic preparations and substances, namely protein receptors used in science and laboratory analysis; ion channel inhibitors for use in the manufacture of pharmaceuticals and drugs; proteins for use in scientific research and analysis relating to genetic diseases; peptides and amino acids for laboratory or research use; in-vivo photo pharmacology diagnostic preparations and substances for laboratory or research use; fluorescent dyes, chemically activated adhesive labels and stains for chemical, bio-chemical and molecular analysis; enzymes and enzymatic preparations and substances for scientific purposes; stem cells other than for medical or veterinary purposes

electronic imaging apparatus in the field of iridology not for medical purposes; DNA chips; downloadable software for use in delivering content in the field of biochemistry, clinical chemistry and microbiology; downloadable medical and scientific software for use in delivering content in the field of biochemistry, clinical chemistry and microbiology; downloadable computer software applications for mobile phones, handheld computers, namely applications for use in delivering content in the field of biochemistry, clinical chemistry and microbiology; downloadable electronic publications, namely, books, magazines, brochures about life sciences for use by medical professionals in the field of science and medicine; downloadable scientific materials, namely, scientific papers, articles; downloadable educational and teaching material in the field of biochemistry, clinical chemistry and microbiology

Advisory and consultancy services relating to scientific research and development; chemical, pharmacology, biological and biochemical research and development services; laboratory research and development services in connection with chemistry, pharmacology, biology, and biochemistry; pharmaceutical research and development services; chemical, biological and biochemical analysis services; molecular biology and genetic research services; chemical, scientific, biological and biochemical research advisory and consultancy services; the provision of tools and printed guides for use in scientific, biological and biochemical research and development and advisory and consultancy services in connection with all of the aforesaid services

Chemical reagents for medical or veterinary purposes; medical diagnostic reagent kits composed of chemical and biological reagents for the treatment, monitoring and diagnosis of disease for medical purposes; molecular test and testing reagents for medical use; in-vivo diagnostic reagents for medical use; laboratory reagents for medical or veterinary use; reagents for laboratory testing for medical or veterinary use; chemical diagnostic reagents for medical or veterinary use; chemical reagents for medical use in the field of life science research and for use in biochemistry, clinical chemistry and microbiology and preparations for medical analysis; biological reagents for medical use in the field of life science research and for use in biochemistry, clinical chemistry and microbiology and preparations for medical analysis; colostral antibodies for medical purposes; chemical products and preparations for use in radio chemical analysis for medical purposes; biochemical preparations and substances for medical, diagnostic or pharmaceutical use; Protein arrays for medical diagnostic purposes; peptides and amino acid preparations for medical purposes; in-vitro photo pharmacology diagnostic preparations and substances for medical use; antibiotics; diagnostic reagents and buffers for medical use; injectable medical dyes and stains for chemical, bio-chemical or molecular analysis for medical diagnostic purposes; enzymes and enzymatic preparations and substances for medical purposes; stem cells for medical or veterinary purposes; pharmaceutical preparations, namely therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders; DNA vaccines; antivirals for pharmaceutical or medical purposes

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 12, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 27, 2025 FICS
FINAL DISPOSITION PROCESSED
Aug 27, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 11, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 28, 2025 OPNX
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 11, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 11, 2025 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 10, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 9, 2025 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 24, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 24, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 18, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 18, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 30, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 30, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 4, 2024 GNFN
FINAL REFUSAL E-MAILED
Apr 4, 2024 GNFR
FINAL REFUSAL WRITTEN
Apr 4, 2024 CNFR
NEW REPRESENTATIVE AT IB RECEIVED
Mar 23, 2024 NREP
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 20, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 20, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 20, 2024 TROA
ATTORNEY REVIEW COMPLETED
Sep 26, 2023 ATRV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Sep 25, 2023 CREV
REFUSAL PROCESSED BY IB
Sep 13, 2023 RFNT
CORRECTION TRANSACTION RECEIVED FROM IB
Sep 10, 2023 CRCV
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 17, 2023 RFCS
REFUSAL PROCESSED BY MPU
Aug 17, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 18, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jul 17, 2023 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 7, 2023 MAFR
ASSIGNED TO EXAMINER
Jul 3, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 3, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 29, 2023 REPR